Skip to main content
logo
CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
104.50
+3.00 (2.96%)
Sep 17, 2026, 1:59 PM CST

CHO Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
21,7226,01411,02214,83025,20415,354
Market Cap Growth
160.26%-45.44%-25.68%-41.16%64.15%235.65%
Enterprise Value
19,7693,8098,56813,94424,03313,969
Last Close Price
101.5028.1051.5069.30137.0083.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12740.214202.443078.64-420067.124300.98
PB Ratio
9.152.444.014.9917.648.80
P/TBV Ratio
11.122.944.745.8327.0612.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-2661.502393.25-400545.333912.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.01-0.010.02
Net Debt / Equity Ratio
-0.82-0.83-0.85-0.87-0.72-0.74
Net Debt / EBITDA Ratio
6.686.539.8310.403.186.99
Net Debt / FCF Ratio
7.827.0810.498.883.996.59
Asset Turnover
0.000.000.00-00.00
Quick Ratio
21.3218.9620.4124.576.199.89
Current Ratio
21.9619.4720.8124.936.3910.06
Return on Equity (ROE)
-10.71%-11.13%-7.41%-13.90%-21.33%-11.11%
Return on Assets (ROA)
-7.24%-7.47%-5.22%-7.17%-12.55%-6.52%
Return on Capital Employed (ROCE)
-12.70%-13.20%-9.00%-9.00%-24.50%-12.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.23%-4.82%-1.93%-2.06%-1.34%-1.34%
FCF Yield
-1.15%-4.80%-2.02%-1.98%-1.03%-1.28%
Buyback Yield / Dilution
---11.86%-4.00%-0.04%-0.12%